Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran of the pharma market research industry, there have been many trends in research that have dominated this annual conference meeting, but this year was different. It wasn’t a trend being discussed, it was a reality – the recognition that AI is here and not going away.

I recall in last year’s meeting (yes, only a year ago!), there were a handful of discussions on the use of AI. The tone of these sessions was about how our industry (known to be a bit of a laggard for innovation) was grappling with the AI Train ready to roar out of the station. A conductor yelling “All Aboard” came to mind, with some ready to jump on and others quite hesitant. I recall a panel discussion of leaders from various client-side organizations and one member saying it scared them as much as Arnold Schwarzenegger’s character in the Terminator.

One year later, it is clear the AI Train has left the station, and it is not a matter of if you are getting on board, it’s a matter of when? At which “stop” will organizations board this supersonic speed train? 

Many agency side presentations this year suggest that most of us are using AI to support content writing and analysis (open-ends, qualitative discussions, etc.). In addition, there were discussions about developing personas with AI and the use of Digital Twins. A few talks provided comparisons of human analysis to AI analysis.

The mood of this conference was excitement, with the acknowledgment of the need to proceed with caution. There was a realization that AI will change the skillsets required to function as a value-add market researcher in this new world. One talk went as far as to suggest that adaptation is a must, much like Darwin and evolution, with a title of the talk named “I Have Said it Before and I Will Say it Again …You are Going to Lose Your Job (Or How Not To).

Being a seasoned researcher, I will admit that a year ago, I was standing on the station platform, intrigued with this AI Train and where it was going. This year, I am on board and excited to see the evolution of our industry, with the hope that we use our innate human intelligence to ensure we are responsible and balanced in our new relationship with our AI Research Accelerator (not Terminator)!  

Blogs & News

Read More
Read More

10 Best Practices in Conducting Ethnography in Rare Disease Population

Rare disease patients face unique challenges that are often overlooked or misunderstood by those…

Read More
Read More

KJT Welcomes Katherine Ephlin as Research, Executive Vice President

KJT, a leader in strategic research insights, real-world evidence and medical communications for…

Read More
Read More

How AI Will Impact the Value of Qualitative Insights

The healthcare industry is experiencing a seismic shift in how market research is conducted and…

Read More
Read More

Navigating Complex Patient Experiences through Qualitative Research

In today’s complex healthcare landscape, understanding patient experiences is more crucial than…

Read More
Read More

Empathy, Integrity, and Mindfulness: The Values that Drive Innovation at KJT 

We are immensely proud of our journey from a nascent market research firm in 2007 to a recognized…

Read More
Read More

Generative AI Message Testing – Does it Really Work? 

Message testing is a crucial process for pharmaceutical and biotech companies when evaluating the…

Read More
healthcare provider using generative AI tools
Read More

Using Generative AI for Patient-Centered Market Research – Reality or Myth? 

No matter where you look, generative AI is becoming commonplace. In the realm of healthcare…

Read More
Read More

3 Reasons Why Working in an ESOP Company is Inspiring

When I first came to the United States from Scotland, I wasn’t fully familiar with the idea of…

Read More
Read More

KJT Welcomes Laura McCormick, PhD

KJT is delighted to announce the appointment of Laura McCormick, PhD as the new Vice President of…

Read More
Read More

Finding the Path to Your Brand’s North Star: The Importance of Enhancing Brand Equity & Tracking Research

In the competitive pharmaceutical and biotech landscapes, the strength of a brand can often be the…

Let’s Take Research Further. Together.